On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries
Alzheimer's & Dementia · 2024-05 · 20 (5) · 3397-3405
DOI: 10.1002/alz.13796 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 02.04.2024. Verfasst von Sanghun Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Consilience, Division of Medicine, Graduate school, Dankook University, Yongin-si, Gyeonggi-do, South Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, Cure Alzheimer's Fund, NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Genome‐wide association studies have identified numerous disease susceptibility loci (DSLs) for Alzheimer's disease (AD). However, only a limited number of studies have investigated the dependence of the genetic effect size of established DSLs on genetic ancestry. METHODS We utilized the whole genome sequencing data from the Alzheimer's Disease Sequencing Project (ADSP) including 35,569 participants. A total of 25,459 subjects in four distinct populations (African ancestry, non‐Hispanic White, admixed Hispanic, and Asian) were analyzed. RESULTS We found that nine DSLs showed significant heterogeneity across populations. Single nucleotide polymorphism (SNP) rs2075650 in translocase of outer mitochondrial membrane 40 ( TOMM40 ) showed the largest heterogeneity (Cochran's Q = 0.00, I 2 = 90.08), followed by other SNPs in apolipoprotein C1 ( APOC1) and apolipoprotein E ( APOE) . Two additional loci, signal‐induced proliferation‐associated 1 like 2 ( SIPA1L2) and solute carrier 24 member 4 ( SLC24A4) , showed significant heterogeneity across populations. DISCUSSION We observed substantial heterogeneity for the APOE ‐harboring 19q13.32 region with TOMM40/APOE/APOC1 genes. The largest risk effect was seen among African Americans, while Asians showed a surprisingly small risk effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Consilience, Division of Medicine, Graduate school, Dankook University, Yongin-si, Gyeonggi-do, South Korea.
- Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Genetics and Aging Unit and McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
- Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, Massachusetts, USA.
ORCID-Profile: Sanghun Lee, Dmitry Prokopenko
Förderung
- NIMH NIH HHS
- Cure Alzheimer's Fund
- NIH HHS
- National Institutes of Health
Zitieren
APA
Lee, S., Hecker, J., Hahn, G., Mullin, K., Alzheimer's Disease Neuroimaging Initiative (ADNI), Lutz, S. M., Tanzi, R. E., Lange, C., & Prokopenko, D. (2024). On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries. Alzheimer's & Dementia, 20(5), 3397-3405. https://doi.org/10.1002/alz.13796
Vancouver
Lee S, Hecker J, Hahn G, Mullin K, Alzheimer's Disease Neuroimaging Initiative (ADNI), Lutz SM, et al. On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries. Alzheimer's & Dementia. 2024;20(5):3397-3405. doi:10.1002/alz.13796
BibTeX
@article{Lee2024,
author = {Lee, Sanghun and Hecker, Julian and Hahn, Georg and Mullin, Kristina and Alzheimer's Disease Neuroimaging Initiative (ADNI), Alzheimer's Disease Neuroimaging Initiative (ADNI) and Lutz, Sharon M and Tanzi, Rudolph E and Lange, Christoph and Prokopenko, Dmitry},
title = {On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {5},
pages = {3397--3405},
doi = {10.1002/alz.13796}
}
EUVIMED